Australia's largest stock trading and investment forum Australia's #1 stock forum

EPN

Click for more information

0.00%

2.4¢ epsilon healthcare limited

you're right. I forgot the dose per day was upped from 60mg to...

First 8 Last

Share
Profile

Follow
whippersnappyr

37 Posts.

10

02/02/21

09:56

Post #: 50629829
Share

Originally posted by nocluegsb: ↑

Possibly but they're suggesting CBD dose range maybe have a U shape for Therapeutic use (i.e. lower and higher ranges). Based of the limited data that's available they are suggesting there is Therapeutic uses for 150mg/day. Although I thought otherwise when tga announced the change, this isn't going to open the flood gates for products to hit the market. The more I read on TGAs site the more it feels like they're pretty much putting it on industry to carry out "high quality published trials" of their own to prove safety and efficacy. They state: "no clear conclusion can be drawn on efficacy of CBD at low doses as larger phase iii and conclusive efficacy trials have not been conducted. i.e. do the trials get the data and the Schedule 3 cbd market is yours in aus? I could be completely off but that's my perspective.
THC global wont be involved in this id suggest. We can produce enough to manufacture and distribute to flood the market if another company wants to link up though?

Expand

you're right. I forgot the dose per day was upped from 60mg to 150mg/day. Still trials and approvals are years way

THC Price at posting: 23.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 34 more messages in this thread...

First 8 Last

Add EPN (ASX) to my watchlist